New Zealand - engelsk - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - dexmedetomidine hydrochloride 0.1182 mg/ml equivalent to dexmedetomidine 0.1mg/ml - concentrate for injection - active: dexmedetomidine hydrochloride 0.1182 mg/ml equivalent to dexmedetomidine 0.1mg/ml excipient: sodium chloride water for injection - for sedation of initially intubated patients during treatment in an intensive care setting. the use of dexmedetomidine hydrochloride ever pharma by continuous intubation in these patents should not exceed 24 hours. for sedation of non-intubated patients prior to and/or during surgical and other procedures.

Belgia - engelsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fresenius kabi sa-nv - dexmedetomidine hydrochloride 0,118 mg/ml - eq. dexmedetomidine 0,1 mg/ml - concentrate for solution for infusion - 100 µg/ml - dexmedetomidine hydrochloride 0.118 mg/ml - dexmedetomidine

Belgia - engelsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fresenius kabi sa-nv - dexmedetomidine hydrochloride 0,118 mg/ml - eq. dexmedetomidine 0,1 mg/ml - concentrate for solution for infusion - 100 µg/ml - dexmedetomidine hydrochloride 0.118 mg/ml - dexmedetomidine

Belgia - engelsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fresenius kabi sa-nv - dexmedetomidine hydrochloride 0,118 mg/ml - eq. dexmedetomidine 0,1 mg/ml - concentrate for solution for infusion - 100 µg/ml - dexmedetomidine hydrochloride 0.118 mg/ml - dexmedetomidine

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - dexmedetomidine hydrochloride, quantity: 472 microgram (equivalent: dexmedetomidine, qty 400 microgram) - injection, concentrated - excipient ingredients: sodium chloride; water for injections - intensive care unit (icu) sedation,for sedation of initially intubated patients during treatment in an intensive care setting. the use of dexmedetomidine kabi by continuous infusion in these patients should not exceed 24 hours.,procedural sedation,for sedation of non-intubated patients prior to and/or during surgical and other procedures.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - dexmedetomidine hydrochloride, quantity: 236 microgram (equivalent: dexmedetomidine, qty 200 microgram) - injection, concentrated - excipient ingredients: sodium chloride; water for injections - intensive care unit (icu) sedation,for sedation of initially intubated patients during treatment in an intensive care setting. the use of dexmedetomidine kabi by continuous infusion in these patients should not exceed 24 hours.,procedural sedation,for sedation of non-intubated patients prior to and/or during surgical and other procedures.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - dexmedetomidine hydrochloride, quantity: 1180 microgram (equivalent: dexmedetomidine, qty 1000 microgram) - injection, concentrated - excipient ingredients: sodium chloride; water for injections - intensive care unit (icu) sedation,for sedation of initially intubated patients during treatment in an intensive care setting. the use of dexmedetomidine kabi by continuous infusion in these patients should not exceed 24 hours.,procedural sedation,for sedation of non-intubated patients prior to and/or during surgical and other procedures.

Canada - engelsk - Health Canada

fresenius kabi canada ltd - dexmedetomidine (dexmedetomidine hydrochloride) - solution - 4mcg - dexmedetomidine (dexmedetomidine hydrochloride) 4mcg

Canada - engelsk - Health Canada

hikma canada limited - dexmedetomidine (dexmedetomidine hydrochloride) - solution - 100mcg - dexmedetomidine (dexmedetomidine hydrochloride) 100mcg

Canada - engelsk - Health Canada

hikma canada limited - dexmedetomidine (dexmedetomidine hydrochloride) - solution - 4mcg - dexmedetomidine (dexmedetomidine hydrochloride) 4mcg